Fostering Global Research Collaborations: An Update on Duke-NUS Medical School, the Duke University and National...

Navigating the complexities of international research collaborations is a challenge. This article provides a detailed examination of the international collaboration between Duke University and the National University of Singapore to establish the Duke-NUS Medical School. It explores the evolution and impact of the partnership, focusing on outcomes, knowledge advancement, and the dynamics of international collaborations in academic medicine.

The partnership began in 2005 and applies a collaborative approach, including aligning research foci with Singapore's national health priorities, the formation of an academic medical center, faculty exchanges, joint funding for pilot research, and pooling of expertise, diverse and multiethnic data, and samples.

The collaboration has led to educational and research advancements, including significant contributions to global health, such as the development of the first U.S. Food and Drug Administration-approved SARS-CoV-2 antigen test and a nasal COVID-19 vaccine candidate. Additionally, it has enhanced academic medicine capabilities within Singapore by transforming teaching hospitals into a fully integrated academic medical center. This experience suggests the following toward advancing the partnership: (1) agreement on and revisiting of the shared vision of the partnership by institutional leaders, (2) middle- and end-period reviews within multiyear funding cycles from local ministries, (3) faculty engagement through collaborative resources and spaces, and (4) similar first languages and health systems of the partners.

The Duke-NUS Medical School partnership aims to expand its research areas to address more global health challenges, such as the impact of climate change on health and the advancement of precision medicine. This article offers valuable insights for understanding the dynamics, benefits, and challenges of international collaborations in academic medicine.